We are dedicated to giving life to science and transforming innovation into value
We do this by enhancing on-target efficacy, enabling oral administration or improving tolerability to unlock new classes of medicine
Our team has overseen R&D of therapeutics supporting more than 15 regulatory approvals and led several multi-billion dollar strategic transactions